Preclinical News and Research

RSS
Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

11 May 2011
Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

11 May 2011
UCLA researchers amp up power of killer CD8 T-cells to fight melanoma

UCLA researchers amp up power of killer CD8 T-cells to fight melanoma

11 May 2011
NTC, Aldevron partner to manufacture first plasmid DNA-based genetic cosmetic

NTC, Aldevron partner to manufacture first plasmid DNA-based genetic cosmetic

11 May 2011
Micromet first quarter total revenues decrease to $5.5 million

Micromet first quarter total revenues decrease to $5.5 million

10 May 2011
Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

10 May 2011
biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

10 May 2011
MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

10 May 2011
Bruker announces new ultra-high field BioSpec 150/11 MRI system for preclinical research at ISMRM 2011

Bruker announces new ultra-high field BioSpec 150/11 MRI system for preclinical research at ISMRM 2011

10 May 2011
OncoGenex first quarter revenue decreases to $1.2 million

OncoGenex first quarter revenue decreases to $1.2 million

10 May 2011
Acceleron presents RAP-661 preclinical data in osteopenic mice at international meeting

Acceleron presents RAP-661 preclinical data in osteopenic mice at international meeting

10 May 2011
Unigene first quarter net loss decreases 58% to $6.6 million

Unigene first quarter net loss decreases 58% to $6.6 million

9 May 2011
Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

9 May 2011
Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

9 May 2011
Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

9 May 2011
Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

7 May 2011
Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

Enzon first quarter adjusted loss from continuing operations decreases to $4.2 million

7 May 2011
Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

6 May 2011
Omeros' PDE7 program expands addiction franchise

Omeros' PDE7 program expands addiction franchise

6 May 2011
MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment

MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment

6 May 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback